Your browser doesn't support javascript.
loading
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Chen, Li-Tzong; Satoh, Taroh; Ryu, Min-Hee; Chao, Yee; Kato, Ken; Chung, Hyun Cheol; Chen, Jen-Shi; Muro, Kei; Kang, Won Ki; Yeh, Kun-Huei; Yoshikawa, Takaki; Oh, Sang Cheul; Bai, Li-Yuan; Tamura, Takao; Lee, Keun-Wook; Hamamoto, Yasuo; Kim, Jong Gwang; Chin, Keisho; Oh, Do-Youn; Minashi, Keiko; Cho, Jae Yong; Tsuda, Masahiro; Sameshima, Hiroki; Kang, Yoon-Koo; Boku, Narikazu.
Afiliação
  • Chen LT; National Institute of Cancer Research, National Health Research Institutes, National Cheng Kung University, Tainan, Taiwan.
  • Satoh T; Department of Internal Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
  • Ryu MH; Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan.
  • Chao Y; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kato K; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Chung HC; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Chen JS; Division of Medical Oncology, Yonsei Cancer Center, Song-Dang Institute for Cancer Research, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.
  • Muro K; Division of Hematology and Oncology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan.
  • Kang WK; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Yeh KH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Yoshikawa T; National Taiwan University Cancer Center, Taipei, Taiwan.
  • Oh SC; Department of Oncology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Bai LY; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
  • Tamura T; Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Lee KW; Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, South Korea.
  • Hamamoto Y; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan.
  • Kim JG; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osakasayama, Japan.
  • Chin K; Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan.
  • Oh DY; Division of Hematology and Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Minashi K; Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
  • Cho JY; Kyungpook National University School of Medicine, Daegu, South Korea.
  • Tsuda M; Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Sameshima H; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Kang YK; Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan.
  • Boku N; Department of Medical Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Gastric Cancer ; 23(3): 510-519, 2020 05.
Article em En | MEDLINE | ID: mdl-31863227
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Terapia de Salvação / Junção Esofagogástrica / Antineoplásicos Imunológicos / Nivolumabe Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Gastric Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Taiwan País de publicação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Terapia de Salvação / Junção Esofagogástrica / Antineoplásicos Imunológicos / Nivolumabe Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Gastric Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Taiwan País de publicação: Japão